KAL1 Antikörper (N-Term)
Kurzübersicht für KAL1 Antikörper (N-Term) (ABIN2294706)
Target
Alle KAL1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 165-194, N-Term
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- KAL1, NT (KAL1, ADMLX, KAL, KALIG1, Anosmin-1, Adhesion molecule-like X-linked, Kallmann syndrome protein)
-
Aufreinigung
- Purified by Protein A affinity chromatography.
-
Immunogen
- KAL1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 165-194 amino acids from the N-terminal region of human KAL1.
-
Isotyp
- IgG
-
-
anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 200-300) antibody
KAL1 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Kallmann Syndrome 1 Sequence (KAL1) antibodyKAL1 Reaktivität: Human, Maus, Ratte IF Wirt: Kaninchen Polyclonal unconjugated
anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 548-657) antibodyKAL1 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 548-657) antibodyKAL1 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 2E8 unconjugated
anti-Kallmann Syndrome 1 Sequence (KAL1) (AA 166-194), (N-Term) antibodyKAL1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB39497 unconjugated
anti-Kallmann Syndrome 1 Sequence (KAL1) (Internal Region) antibodyKAL1 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
-
